Advertisement
Screener

LISATA THERAPEUTICS, INC. (LSTA) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

LISATA THERAPEUTICS, INC. Cash Flow Breakdown

Cash flow breakdown shows where LISATA THERAPEUTICS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $15.95M went out.
  • Fiscal year ended 2025-12-31: from investing, $15.09M came in.
  • Fiscal year ended 2025-12-31: from financing, $599.00K came in.
  • Fiscal year ended 2025-12-31: change in cash, $253.00K went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDividendsDebt paid backNew debtStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$15.95M$15.09M-$253.00K$844.00K-$253.00K
2024-12-31-$19.36M$13.23M-$274.00K$68.00K-$6.38M
2023-12-31-$20.03M$10.10M-$91.00K$321.00K-$9.56M
2022-12-31-$21.17M$28.91M-$267.00K$43.00K$7.51M
2021-12-31-$22.25M-$54.90M-$248.00K$85.50M$8.13M
2020-12-31-$8.82M-$7.28M-$148.00K$18.73M$2.48M
2019-12-31-$18.88M$21.43M-$130.00K$0.00$1.31M*$3.73M
2018-12-31-$19.99M-$4.71M$0.00-$403.00K*$355.00K-$23.87M
2017-12-31-$20.88M$41.27M-$5.65M-$358.00K$13.00K$5.06M*$19.46M
2016-12-31-$23.67M-$2.85M-$9.35M-$72.01K$0.00$30.32M*-$5.61M
2015-12-31-$39.26M$3.80M$0.00$0.00$0.00$0.00$36.60M*$1.14M
2014-12-31-$46.90M-$10.74M$0.00$15.00M$271.01K$15.40M*-$26.96M
2013-12-31-$27.10M-$2.69M$0.00$0.00$150.66K$62.04M*$32.40M
2012-12-31-$13.85M$6.09M-$327.75K$0.00$0.00$9.07M*$992.02K
2011-12-31-$20.93M-$2.05M$0.00$7.10K$20.06M*-$2.87M
2010-12-31-$8.48M-$17.11M$222.92K$33.63M*$8.45M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDividendsDebt paid backNew debtStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$2.65M*$0.00*$0.00*$29.00K*
2026-03-31-$3.08M$0.00-$159.00K$0.00-$2.90M
2025-12-31-$3.25M*$0.00*$0.00*$205.00K*
2025-09-30-$3.34M*$5.15M*$0.00*$353.00K*
2025-06-30-$3.96M*$505.00K*-$10.00K*$74.00K*
2025-03-31-$5.40M$9.43M-$243.00K$212.00K$4.01M
2024-12-31-$4.53M*$1.39M*-$132.00K*$36.00K*
2024-09-30-$2.52M*-$6.30M*$0.00*$0.00*
2024-06-30-$5.28M*$11.71M*$0.00*$32.00K*
2024-03-31-$7.03M$6.44M-$142.00K$0.00-$788.00K
2023-12-31-$4.07M*-$5.71M*$0.00*$24.00K*
2023-09-30-$3.58M*$12.25M*-$6.00K*$0.00*
2023-06-30-$4.18M*-$725.00K*$0.00*$155.00K
2023-03-31-$8.20M$4.29M-$85.00K-$4.00M
2022-12-31-$6.47M*$7.11M*$0.00*$14.00K*
2022-09-30-$4.00M*$2.26M*-$99.00K*$0.00*
2022-06-30-$5.06M*$25.63M*$0.00*$29.00K*
2022-03-31-$5.64M-$6.09M-$168.00K$0.00-$11.90M
2021-12-31-$4.60M*$16.46M*$0.00*$21.00K*
2021-09-30-$5.04M*$4.94M*-$64.00K*$0.00*
2021-06-30-$4.63M*-$11.20M*$0.00*$22.00K*
2021-03-31-$7.97M-$65.09M-$184.00K$85.46M$12.23M
2020-12-31-$5.57M*$910.00K*$0.00*$13.00K*
2020-09-30-$3.52M*-$11.04M*$0.00*$9.03M*
2020-06-30$4.50M*-$8.25M*$0.00*$9.68M*
2020-03-31-$4.24M$11.10M-$148.00K$0.00$6.71M
2019-12-31-$4.22M*$5.30M*$0.00*$0.00*
2019-09-30-$4.46M*$5.38M*$0.00*$0.00*
2019-06-30-$4.72M*$2.01M*$0.00*$0.00*
2019-03-31-$5.49M$8.74M-$130.00K$0.00$1.00M*$4.13M
2018-12-31-$3.04M*-$1.07M*$0.00*$0.00*$0.00*
2018-09-30-$4.76M*-$4.29M*$0.00*$0.00*$13.00K*$687.00K*
2018-06-30-$5.88M*$1.84M*$0.00*-$358.00K*$302.00K*
2018-03-31-$6.30M-$1.19M$0.00-$45.00K$40.00K-$7.56M
2017-12-31-$3.97M*$18.23M*$354.00*-$335.00*-$576.00*
2017-09-30-$6.33M*-$3.79M*$0.00*$0.00*$0.00*$2.16M*
2017-06-30-$488.49K*$27.00M*-$4.89M*-$334.02K*$13.58K*-$5.25M*$11.05M*
2017-03-31-$10.09M-$171.28K-$756.97K-$23.65K$0.00$8.33M*-$2.71M
2016-12-31-$3.38M*-$533.54K*$0.00*-$72.01K*$0.00*-$3.90M*
2016-09-30-$5.72M*-$612.46K*-$3.00M*$0.00*$0.00*$10.24M*$907.06K*
2016-06-30-$6.55M*-$658.47K*$0.00*$0.00*$0.00*-$520.75K*-$7.73M*
2016-03-31-$8.03M-$1.04M-$6.35M$11.70M$0.00$0.00$8.83M*$5.11M
2015-12-31-$8.73M*$4.72M*$0.00*$0.00*$0.00*-$3.72M*
2015-09-30-$8.70M*-$3.15M*$0.00*$0.00*$0.00*-$12.17M*
2015-06-30-$7.59M*-$4.47M*$0.00*$0.00*$0.00*$29.14M*$17.08M*
2015-03-31-$14.24M$6.70M$0.00$11.70M$0.00-$4.21M*-$42.78K
2014-12-31-$10.90M*-$7.19M*$523.83K*$0.00*$4.60M*-$12.97M*
2014-09-30-$13.49M*-$239.15K*$40.83K*$12.96M*-$723.78K*
2014-06-30-$11.25M*-$2.07M*$158.82K*$4.67M*-$8.49M*
2014-03-31-$11.25M-$1.24M$71.36K$7.65M*-$4.77M
2013-12-31-$7.36M*-$1.74M*$0.00*$64.00K*$38.23M*$29.19M*
2013-09-30-$6.61M*-$680.11K*$86.66K*$9.43M*$2.22M*
2013-06-30-$5.99M*-$214.96K*$0.00*$11.67M*$5.47M*
2013-03-31-$7.14M-$53.57K$0.00$2.71M*-$4.48M
2012-12-31-$9.62M*$8.78M*-$270.90K*$0.00*-$1.41M*-$2.44M*
2012-09-30-$3.38M*-$371.31K*-$25.15K*$0.00*$1.72M*-$2.08M*
2012-06-30-$2.96M*-$2.21M*$1.54M*-$3.61M*
2012-03-31$2.11M-$110.07K$7.19M*$9.13M
2011-12-31-$3.41M*$1.07M*$0.00*$0.00*$3.55M*$1.03M*
2011-09-30-$4.26M*$3.29M*$0.00*$0.00*$7.67M*$6.86M*
2011-06-30-$3.07M*-$3.31M*$1.77M*-$4.56M*
2011-03-31-$10.20M-$3.10M$7.08M*-$6.20M
2010-12-31-$5.30M*-$6.09M*$445.85K*$22.42M*$11.55M*
2010-09-30$288.75K*-$2.98M*-$2.00*-$4.21M*-$6.89M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
BIOVIE INC. (BIVI)United States$0.012B